Thursday, 18 June 2026

Biologics

Biologics are complex, cutting-edge medications derived from living organisms (such as human cells, animals, or microorganisms) rather than synthesized from chemicals. They are designed to target specific parts of the immune system and treat complex diseases like cancers, autoimmune disorders, and genetic conditions. 
Key Characteristics
  • Complex Molecules: Unlike conventional drugs (like aspirin), biologics are large, intricate molecules made of proteins, sugars, or nucleic acids.  
  • Living Production: They are grown in living systems like bacterial cultures, yeast, or animal cells. 
  • Delivery Method: Because they are large, they are usually broken down by the digestive tract. Therefore, they are typically administered via injection or intravenous (IV) infusion. 
  • High Cost: They are expensive and highly intricate to manufacture, but they often treat conditions with few other alternatives. 
Common Types of Biologics
  • Monoclonal Antibodies (mAbs): Highly specific proteins designed to seek out and bind to targets, often used to help the immune system identify and destroy cancer cells.
  • Vaccines: Introduce weakened or inactive parts of a pathogen to stimulate your immune system to create antibodies.
  • Gene Therapies: Introduce, replace, or alter a gene within a patient's cells to treat a genetic disease.
  • Hormones: Recombinant versions of natural hormones (e.g., insulin) used to replace those your body cannot produce. 
Biologics vs. Biosimilars
Because biologic medications are grown in living cells, they cannot be copied exactly, meaning no two production batches are identical. Instead of "generic" equivalents, biologics have biosimilars. A biosimilar is an FDA-approved biologic that is highly similar to an original biologic, showing no clinically meaningful differences in safety, purity, or potency.